Cointime

OptiScan Biomedical

company

About

OptiScan Biomedical develops glucose monitoring systems to assist healthcare providers to manage the glucose level of the patients.

  • 51 - 100

Highlights

Total Funding Amount
$36M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$36M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 1994
Number Of Employee
51 - 100
Operating Status
Active

OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$36M
OptiScan Biomedical has raised a total of $36M in funding over 2 rounds. Their latest funding was raised on Oct 10, 2005 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 10, 2005 Series Unknown $36M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
OptiScan Biomedical is funded by 1 investors. EGS Healthcare Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
EGS Healthcare Capital Partners — Series Unknown
Cointime
İçerikler
Şirket.